title: Cerebral schistosomiasis.
authors.affiliation: Department of Infectious Diseases, Addenbrooke's Hospital, Cambridge, UK. Mark.Roberts@worcsacute.wmids.nhs.uk
authors.forename: Mark
authors.initials: M
authors.lastname: Roberts
authors.forename: Justin
authors.initials: J
authors.lastname: Cross
authors.forename: Ute
authors.initials: U
authors.lastname: Pohl
authors.forename: Sebastian
authors.initials: S
authors.lastname: Lucas
authors.forename: Andrew
authors.initials: A
authors.lastname: Dean
mesh_terms: D000328:Adult; D000871:Anthelmintics / Q000627:therapeutic use*; D001927:Brain Diseases / Q000188:drug therapy / Q000469:parasitology*; D002220:Carbamazepine / Q000627:therapeutic use; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D020818:Neuroschistosomiasis / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology*; D011223:Praziquantel / Q000627:therapeutic use; D012555:Schistosomiasis mansoni / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology*
chemical_list: D000871:Anthelmintics; D002220:Carbamazepine; D011223:Praziquantel